US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 2.0373
  • -0.0327-1.58%
Trading Mar 25 13:08 ET
34.46MMarket Cap-0.86P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-33.53%18.5M
-44.80%2.43M
-47.97%3.02M
-13.90%7.05M
-36.43%6M
-37.21%27.84M
-55.44%4.41M
-36.46%5.81M
-14.71%8.19M
-39.92%9.44M
Selling and administrative expenses
-5.00%13.51M
38.78%2.6M
-3.33%2.41M
4.45%4.25M
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
-General and administrative expense
-5.00%13.51M
38.78%2.6M
-3.33%2.41M
4.45%4.25M
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
-50.24%2.49M
-38.80%4.07M
-43.41%5.79M
Research and development costs
-53.64%6.2M
-59.12%1.04M
-81.56%611K
-27.60%2.8M
-52.11%1.75M
-21.47%13.37M
-43.13%2.53M
-19.74%3.31M
30.93%3.87M
-33.43%3.65M
Other operating expenses
-580.80%-1.2M
----
----
----
----
--250K
--0
----
--250K
----
Operating profit
33.53%-18.5M
44.80%-2.43M
47.97%-3.02M
13.90%-7.05M
36.43%-6M
37.21%-27.84M
55.44%-4.41M
36.46%-5.81M
14.71%-8.19M
39.92%-9.44M
Net non-operating interest income expense
-149.73%-186K
166.67%4K
-92.41%6K
-95.17%7K
-230.13%-203K
50.20%374K
-104.51%-6K
-16.84%79K
530.43%145K
5,300.00%156K
Non-operating interest income
-91.09%44K
-94.59%4K
-94.96%6K
-95.17%7K
-82.69%27K
98.39%494K
-43.08%74K
25.26%119K
530.43%145K
--156K
Non-operating interest expense
91.67%230K
--0
--0
--0
--230K
--120K
2,766.67%80K
--40K
--0
--0
Other net income (expense)
-139.60%-6.44M
-8,412.50%-6.65M
518.32%1.39M
-26.71%-854K
81.42%-327K
-162.03%-2.69M
116.46%80K
-800.00%-333K
-125.97%-674K
-177.88%-1.76M
Gain on sale of security
-8,385.00%-1.66M
-26,057.14%-1.83M
534.62%165K
263.64%18K
-175.00%-9K
-92.16%20K
-136.84%-7K
170.27%26K
-109.48%-11K
-92.36%12K
Special income (charges)
----
----
---127K
----
----
----
----
--0
----
----
-Less:Other special charges
----
----
--127K
----
----
----
----
----
----
----
Other non- operating income (expenses)
-76.62%-4.78M
-5,785.06%-4.95M
477.44%1.36M
-31.52%-872K
82.05%-318K
-436.04%-2.71M
--87K
---359K
---663K
---1.77M
Income before tax
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
Income tax
Net income
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
Net income continuous Operations
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
Minority interest income
Net income attributable to the parent company
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
Preferred stock dividends
Other preferred stock dividends
0
9K
Net income attributable to common stockholders
16.69%-25.13M
-109.12%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.14%-30.16M
57.61%-4.34M
33.26%-6.06M
-24.85%-8.72M
17.91%-11.04M
Basic earnings per share
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
55.42%-7.4
33.67%-3.98
66.67%-0.5
47.14%-0.74
-10.00%-1.21
-690.48%-16.6
Diluted earnings per share
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
55.42%-7.4
33.67%-3.98
66.67%-0.5
47.14%-0.74
-10.00%-1.21
-690.48%-16.6
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -33.53%18.5M-44.80%2.43M-47.97%3.02M-13.90%7.05M-36.43%6M-37.21%27.84M-55.44%4.41M-36.46%5.81M-14.71%8.19M-39.92%9.44M
Selling and administrative expenses -5.00%13.51M38.78%2.6M-3.33%2.41M4.45%4.25M-26.53%4.25M-47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M
-General and administrative expense -5.00%13.51M38.78%2.6M-3.33%2.41M4.45%4.25M-26.53%4.25M-47.94%14.22M-65.54%1.87M-50.24%2.49M-38.80%4.07M-43.41%5.79M
Research and development costs -53.64%6.2M-59.12%1.04M-81.56%611K-27.60%2.8M-52.11%1.75M-21.47%13.37M-43.13%2.53M-19.74%3.31M30.93%3.87M-33.43%3.65M
Other operating expenses -580.80%-1.2M------------------250K--0------250K----
Operating profit 33.53%-18.5M44.80%-2.43M47.97%-3.02M13.90%-7.05M36.43%-6M37.21%-27.84M55.44%-4.41M36.46%-5.81M14.71%-8.19M39.92%-9.44M
Net non-operating interest income expense -149.73%-186K166.67%4K-92.41%6K-95.17%7K-230.13%-203K50.20%374K-104.51%-6K-16.84%79K530.43%145K5,300.00%156K
Non-operating interest income -91.09%44K-94.59%4K-94.96%6K-95.17%7K-82.69%27K98.39%494K-43.08%74K25.26%119K530.43%145K--156K
Non-operating interest expense 91.67%230K--0--0--0--230K--120K2,766.67%80K--40K--0--0
Other net income (expense) -139.60%-6.44M-8,412.50%-6.65M518.32%1.39M-26.71%-854K81.42%-327K-162.03%-2.69M116.46%80K-800.00%-333K-125.97%-674K-177.88%-1.76M
Gain on sale of security -8,385.00%-1.66M-26,057.14%-1.83M534.62%165K263.64%18K-175.00%-9K-92.16%20K-136.84%-7K170.27%26K-109.48%-11K-92.36%12K
Special income (charges) -----------127K------------------0--------
-Less:Other special charges ----------127K----------------------------
Other non- operating income (expenses) -76.62%-4.78M-5,785.06%-4.95M477.44%1.36M-31.52%-872K82.05%-318K-436.04%-2.71M--87K---359K---663K---1.77M
Income before tax 16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M
Income tax
Net income 16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M
Net income continuous Operations 16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M
Minority interest income
Net income attributable to the parent company 16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M33.26%-6.06M-24.85%-8.72M17.91%-11.04M
Preferred stock dividends
Other preferred stock dividends 09K
Net income attributable to common stockholders 16.69%-25.13M-109.12%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.14%-30.16M57.61%-4.34M33.26%-6.06M-24.85%-8.72M17.91%-11.04M
Basic earnings per share 40.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7555.42%-7.433.67%-3.9866.67%-0.547.14%-0.74-10.00%-1.21-690.48%-16.6
Diluted earnings per share 40.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7555.42%-7.433.67%-3.9866.67%-0.547.14%-0.74-10.00%-1.21-690.48%-16.6
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Enerpac Tool
EPAC
+7.45%
Precision Drilling
PDS
+1.98%
Cars.com
CARS
+1.06%
Workday
WDAY
+0.70%
Halozyme Therapeutics
HALO
+0.66%

Unlock the Full List